These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 4203064)

  • 21. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
    Germain RN; Williams RM; Benacerraf B
    Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The genetic control of T cell-meditated immunity. I. Characterization of a mouse strain whose low responsiveness is inherited as a recessive trait.
    Vachek H; Kölsch E
    Immunology; 1974 Oct; 27(4):507-15. PubMed ID: 4215740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenetic disparity and graft-versus-host reactions.
    Bach ML; Bach FH
    Semin Hematol; 1974 Jul; 11(3):291-303. PubMed ID: 4151845
    [No Abstract]   [Full Text] [Related]  

  • 24. In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes.
    Rouse BT; Wagner H; Harris AW
    J Immunol; 1972 May; 108(5):1353-61. PubMed ID: 4623947
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of heterologous antilymphocyte serum on the formation of H-2 antibody and the induction of allograft immunity.
    Monaco AP; Franco DJ
    Transplant Proc; 1969 Mar; 1(1):474-8. PubMed ID: 4944263
    [No Abstract]   [Full Text] [Related]  

  • 26. Quantitative effects of nutritional protein and calorie deficiency upon immune responses to tumors in mice.
    Jose DG; Good RA
    Cancer Res; 1973 Apr; 33(4):807-12. PubMed ID: 4633154
    [No Abstract]   [Full Text] [Related]  

  • 27. Plaque assay for the detection of alloantibody-producing cells in mice.
    Wong AK; Sabbadini E
    J Immunol; 1974 Jun; 112(6):2251-9. PubMed ID: 4596699
    [No Abstract]   [Full Text] [Related]  

  • 28. Cell-mediated antitumor immune reactions under syngeneic conditions.
    Leclerc JC; Senik A; Gomard E; Plata F; Levy JP
    Transplant Proc; 1973 Dec; 5(4):1431-4. PubMed ID: 4359721
    [No Abstract]   [Full Text] [Related]  

  • 29. Specificity of heterologous antisera to components solubilized from rat thymocyte membranes.
    Eshhar Z
    Eur J Immunol; 1973 Nov; 3(11):668-73. PubMed ID: 4589167
    [No Abstract]   [Full Text] [Related]  

  • 30. Cell-mediated immune responses in vitro. V. A comparative study of in vitro immunogenicity of splenic lymphocytes, neoplastic lymphoid cells and fibroblats.
    Wagner H; Wyss C
    Eur J Immunol; 1973 Sep; 3(9):549-55. PubMed ID: 4271926
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of two bisdioxopiperazines on mouse B-and T-cell function.
    Dennert G; Hatlen LE; Tucker DF
    J Natl Cancer Inst; 1975 Mar; 54(3):621-9. PubMed ID: 804564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An effector-cell independent step in target cell lysis by sensitized mouse lymphocytes.
    Martz E; Benacerraf B
    J Immunol; 1973 Nov; 111(5):1538-45. PubMed ID: 4200780
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies of allograft immunity in mice. I. Induction, development and in vitro assay of cellular immunity.
    Brunner KT; Mauel J; Rudolf H; Chapuis B
    Immunology; 1970 Apr; 18(4):501-15. PubMed ID: 4986975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxicity of vivo sensitized lymphocytes on allogeneic third-party fibroblasts differing for various regions of the H-2 complex.
    Jorgensen PN; Florentz K; Güttler F
    Transplant Proc; 1974 Mar; 6(1):95-9. PubMed ID: 4817057
    [No Abstract]   [Full Text] [Related]  

  • 35. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. IV. Lymph node immunoreactivity and cell-mediated cytotoxicity.
    Laatikainen A; Syrjänen K; Mäntyjärvi R; Tosi P
    Neoplasma; 1987; 34(4):431-9. PubMed ID: 3116439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recognition of transplantation antigen in vitro: blocking of recognition structures by specific antibody.
    Ramseier H; Lindenmann J
    Eur J Immunol; 1971 Nov; 1(5):348-51. PubMed ID: 4945638
    [No Abstract]   [Full Text] [Related]  

  • 37. Antibody-forming cells with specificity for syngeneic and allogeneic (thymocyte) tissue antigens following lipopolysaccharide mitogenic stimulation.
    McHugh YH; Bonavida B
    Transplant Proc; 1977 Mar; 9(1):1205-9. PubMed ID: 68566
    [No Abstract]   [Full Text] [Related]  

  • 38. Acceptance of phenotypically differing cultured skin in man and mice.
    Summerlin WT; Broutbar C; Foanes RB; Payne R; Stutman O; Hayflick L; Good RA
    Transplant Proc; 1973 Mar; 5(1):707-10. PubMed ID: 4633094
    [No Abstract]   [Full Text] [Related]  

  • 39. [In vitro quantitative determination of the cellular response to skin allografts in mice].
    Degiovanni G
    C R Seances Soc Biol Fil; 1972; 166(4):722-7. PubMed ID: 4568591
    [No Abstract]   [Full Text] [Related]  

  • 40. Presensitization and clinical kidney transplantation. II. Correlative studies of humoral and cellular immunity and clinical course.
    Myburgh JA; Maier G; Smit JA; Shapiro M; Meyers AM; Rabkin R; Van Blerk PJ; Jersky J
    Transplantation; 1974 Sep; 18(3):213-22. PubMed ID: 4607999
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.